Annovis Bio (FRA:07X) FFO


FRA:07X Annovis Bio Inc FRA:07X
32 GF Score
Price €1.42
! 1 Warning Sign
View Full Analysis

What is Annovis Bio FFO?

FFO (Funds from operations) only applies to REITs.

FRA:07X
32GF Score
Annovis Bio Inc FRA:07X
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Annovis Bio Business Description

Other Exchanges ANVS:USA
Address 101 Lindenwood Drive, Suite 225, Malvern, PA, USA, 19355
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.
32GF Score

Get the complete analysis for FRA:07X

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.42
Price